Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:236 (2 February), doi:10.1136/bmj.39475.341296.DB
Janice Hopkins Tanne
1 New York
| The first 150 words of the full text of this article appear below. |
The Institute of Medicine, part of the US National Academy of Sciences, recommended last week that the country needs an independent programme to evaluate "which diagnostic, treatment, and prevention services work best for various patients and circumstances."
The institutes report proposes a single entity to provide "credible, unbiased information." It would be overseen by an advisory board "constituted to minimize bias," and its scope seems to be similar to that of the United Kingdoms National Institute for Health and Clinical Excellence (NICE).
"Under the status quo, the quality of systematic reviews is variable and findings are often unreliable even when published in peer-reviewed scientific journals," the report says.
Hundreds, even thousands, of competing guidelines exist, and there is uncertainty about which are reliable and objective. Guidelines that are paid for by manufacturers or vendors, as many are, are more likely to show effectiveness.
"Unfortunately, the current processes underlying guideline development
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses